164 related articles for article (PubMed ID: 38333510)
41. Three year outcomes of intravitreal ranibizumab and aflibercept treatment of patients with diabetic macular edema: A comparative study.
Akbas YB; Alagoz C; Cakmak S; Demir G; Alagoz N; Artunay HO
Ther Adv Ophthalmol; 2023; 15():25158414231195174. PubMed ID: 37649968
[TBL] [Abstract][Full Text] [Related]
42. Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor.
Eris E; Perente I; Erdogan G; Seymen Z; Sucu ME; Ozkaya A; Demircan A; Alkin Z; Demirok A; Artunay O
Beyoglu Eye J; 2019; 4(1):11-16. PubMed ID: 35187425
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis.
Chi SC; Kang YN; Huang YM
Sci Rep; 2023 May; 13(1):7428. PubMed ID: 37156823
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of switching therapy to aflibercept for patients with persistent diabetic macular edema: a systematic review and meta-analysis.
Liu Y; Cheng J; Gao Y; Qin L; Min X; Zhang M
Ann Transl Med; 2020 Mar; 8(6):382. PubMed ID: 32355826
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
46. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
47. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
Liu X; Zhou X; Wang Z; Li T; Jiang B
Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study.
Mathis T; Papegaey M; Ricard C; Rezkallah A; Matonti F; Sudhalkar A; Vartin C; Dot C; Kodjikian L
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456557
[TBL] [Abstract][Full Text] [Related]
49. Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
Ehlers JP; Yeh S; Maguire MG; Smith JR; Mruthyunjaya P; Jain N; Kim LA; Weng CY; Flaxel CJ; Schoenberger SD; Kim SJ
Ophthalmology; 2022 Jan; 129(1):88-99. PubMed ID: 34446301
[TBL] [Abstract][Full Text] [Related]
50. Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials.
Wei Q; Chen R; Lou Q; Yu J
Drug Des Devel Ther; 2019; 13():301-307. PubMed ID: 30666092
[TBL] [Abstract][Full Text] [Related]
51. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
52. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
Maloney MH; Schilz SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ
Ophthalmology; 2019 Jul; 126(7):1007-1015. PubMed ID: 30292542
[TBL] [Abstract][Full Text] [Related]
53. Comparative Efficacy of Pharmacotherapy for Macular Edema Secondary to Retinal Vein Occlusion: A Network Meta-analysis.
Gao S; Zhang Y; Li X; Ge G; Duan J; Lei C; Zeng Y; Cai Z; Zhang M
Front Pharmacol; 2021; 12():752048. PubMed ID: 34955825
[No Abstract] [Full Text] [Related]
54. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.
Wirkkala J; Kubin AM; Ohtonen P; Yliselä J; Siik T; Hautala N
BMC Ophthalmol; 2022 Jun; 22(1):258. PubMed ID: 35681133
[TBL] [Abstract][Full Text] [Related]
55. Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy.
Xavier T; Pallikara S; Saji N; Radhakrishnan N; Menon KN; Pillai GS
Indian J Ophthalmol; 2021 Jun; 69(6):1475-1481. PubMed ID: 34011723
[TBL] [Abstract][Full Text] [Related]
56. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
[TBL] [Abstract][Full Text] [Related]
57. Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice.
Gurung RL; FitzGerald LM; Liu E; McComish BJ; Kaidonis G; Ridge B; Hewitt AW; Vote BJ; Verma N; Craig JE; Burdon KP
Int J Retina Vitreous; 2023 Apr; 9(1):23. PubMed ID: 37016462
[TBL] [Abstract][Full Text] [Related]
58. The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis.
Zhang L; Wang W; Gao Y; Lan J; Xie L
PLoS One; 2016; 11(7):e0159553. PubMed ID: 27434498
[TBL] [Abstract][Full Text] [Related]
59. Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor.
Savur F; Kaldırım H; Atalay K; Öğreden T; Hayat ŞÇ
BMC Ophthalmol; 2022 Dec; 22(1):508. PubMed ID: 36550418
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema.
Mahapatra SK; Parhi A; Shree P; Mohanty A
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S106-S110. PubMed ID: 38131551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
